Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MICROLET®NEXT Lancet

K-Number: K241810 · 2024-08-15

Decision Date2024-08-15
Product CodeQRK
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MICROLET®NEXT Lancet is a medical device manufactured by Ascensia Diabetes Care U.S., Inc.. It received FDA 510(k) clearance on 2024-08-15 under approval number K241810. The device is classified under product code QRK. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MICROLET®NEXT Lancet?

MICROLET®NEXT Lancet is a medical device that received FDA 510(k) clearance on 2024-08-15. It is manufactured by Ascensia Diabetes Care U.S., Inc.. The 510(k) number is K241810.

When was MICROLET®NEXT Lancet approved by the FDA?

MICROLET®NEXT Lancet received FDA 510(k) clearance on 2024-08-15, under approval number K241810.

What company makes MICROLET®NEXT Lancet?

MICROLET®NEXT Lancet is manufactured by Ascensia Diabetes Care U.S., Inc..

What is the FDA product code for MICROLET®NEXT Lancet?

The FDA product code for MICROLET®NEXT Lancet is QRK.

Other Devices by Ascensia Diabetes Care U.S., Inc.

View all 7 devices →

Related Devices (Code: QRK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.